CureSound

Company Overview

Snapshot

Founded in September 2010, CureSound operates with 1–10 employees. The company has raised $600,000 across one funding round from one investor. In November 2017, the company received FDA clearance for its BRH-A2 device to treat serious wounds.

Business overview

CureSound specializes in noninvasive medical devices within the Health Tech & Life Sciences sector. The company develops the BRH-A wound-healing series, with its flagship product, the BRH-A2, being an FDA-cleared portable device. This technology is designed to heal chronic ulcers, reduce lesion size, alleviate wound pain, and accelerate tissue regrowth through a combination of therapeutic ultrasound and electrostimulation. CureSound serves markets globally, including South Africa and India, targeting healthcare providers, clinics, and patients, particularly seniors and those with chronic conditions like diabetes.

Strategic signal

In November 2017, CureSound's BRH-A2 device received FDA clearance for treating serious wounds using electric fields and ultrasound. This regulatory approval is a significant validation of the company's noninvasive wound-healing technology, signaling its readiness for broader market adoption and enhancing its credibility within the medical device industry. For investors, this indicates a key milestone achieved in product commercialization and market access.

Company Intelligence Q&A

What is CureSound's primary product?

CureSound's primary product is the BRH-A2, a noninvasive, FDA-cleared portable device designed for wound healing. It utilizes a combination of therapeutic ultrasound and electrostimulation to treat chronic ulcers, reduce lesion size, lessen pain, and accelerate tissue regrowth.

When did CureSound receive FDA clearance for its BRH-A2 device?

In November 2017, CureSound's BRH-A2 device received FDA clearance to treat serious wounds using electric fields and ultrasound.

Has CureSound secured any patents for its technology?

In November 2016, CureSound received patents in both the USA and China for its innovative wound healing therapy.

What was a notable early achievement for CureSound?

CureSound won the 8200 Israeli Startup Competition in June 2013.

What is the total funding CureSound has raised?

CureSound has raised a total of $600,000 across one funding round. This funding was secured prior to November 2016, as indicated by the company's patent news.